Archives

LinKinVax has the trust of world-class partners and investors.

News & events

September 19, 2023

Vaccin thérapeutique : un premier patient traité pour un canceroropharyngé HPV-positif dans un essai à Gustave Roussy

CLICK HERE
PDF LINK

LinKinVax and Gustave Roussy announced first patient dosedin Phase I/IIa clinical study on HPV.DCVax in HPV-positiveoropharyngeal cancer

Click here

LinKinVax and Gustave Roussy announced first patient dosedin Phase I/IIa clinical study on HPV.DCVax in HPV-positiveoropharyngeal cancer

Click here

LinKinVax completes first batch production of “pancov”,its next generation multi-variant vaccine against covid and other coronaviruses

Click here

LinKinVax completes first batch production of “pancov”,its next generation multi-variant vaccine against covid and other coronaviruses

Click here

LinKinVax introduces its Scientific Advisory
Board with the appointment of three leading
experts in immunology and epidemiology

Click here

LinKinVax introduces its Scientific Advisory
Board with the appointment of three leading
experts in immunology and epidemiology

Click here

LinKinVax welcomes interim results of the ANRS
VRI06 Phase I trial evaluating a novel HIV vaccine

Click here

LinKinVax welcomes interim results of the ANRS
VRI06 Phase I trial evaluating a novel HIV vaccine

Click here

press releases

No data was found